Reply to Editorial Comment on “Validation and Testing of an In Vitro Model to Study Medical Treatments for Anterior Urethral Stricture Disease: Assessing the Potential Efficacy of Phosphodiesterase-4 (Pde4) Inhibition and Testosterone”
Reply to Editorial Comment on “Validation and Testing of an In Vitro Model to Study Medical Treatments for Anterior Urethral Stricture Disease: Assessing the Potential Efficacy of Phosphodiesterase-4 (Pde4) Inhibition and Testosterone”. // Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0090429526005753?dgcid=rss_sd_all
Reply to Editorial Comment on “Validation and Testing of an In Vitro Model to Study Medical Treatments for Anterior Urethral Stricture Disease: Assessing the Potential Efficacy of Phosphodiesterase-4 (Pde4) Inhibition and Testosterone”. Urology. https://www.sciencedirect.com/science/article/pii/S0090429526005753?dgcid=rss_sd_all
“Reply to Editorial Comment on “Validation and Testing of an In Vitro Model to Study Medical Treatments for Anterior Urethral Stricture Disease: Assessing the Potential Efficacy of Phosphodiesterase-4 (Pde4) Inhibition and Testosterone”.” Urology.
@article{article71028,
title = {Reply to Editorial Comment on “Validation and Testing of an In Vitro Model to Study Medical Treatments for Anterior Urethral Stricture Disease: Assessing the Potential Efficacy of Phosphodiesterase-4 (Pde4) Inhibition and Testosterone”},
journal = {Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0090429526005753?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...